id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-P-0273-0005,FDA,FDA-2009-P-0273,"Determination that Product Withdrawal From Sale for Was Not Due Reasons of Safety or Effectiveness: Amphetamine Sulfate, 5 and 10 Milligram Tablets",Notice,N-Notice,2010-11-10T05:00:00Z,2010,11,2010-11-10T05:00:00Z,,2010-11-10T15:48:04Z,2010-28358,0,0,0900006480b86164
FDA-2009-P-0273-0004,FDA,FDA-2009-P-0273,"FDA/CDER Interim Response to Lachman Consultant Services, Inc. - Letter",Other,LET-Letter,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2013-07-27T23:02:16Z,,0,0,0900006480a69fe3
FDA-2009-P-0273-0003,FDA,FDA-2009-P-0273,"Lachman Consultant Services, Inc. - Supplement",Other,SUP-Supplement,2009-11-19T05:00:00Z,2009,11,2009-11-19T05:00:00Z,,2013-08-11T01:30:59Z,,0,0,0900006480a56569
FDA-2009-P-0273-0001,FDA,FDA-2009-P-0273,"Lachman Consultant Services, Inc. - Citizen Petition",Other,CP-Citizen Petition,2009-06-18T04:00:00Z,2009,6,2009-06-18T04:00:00Z,,2013-07-27T22:47:13Z,,0,0,09000064809d074b
FDA-2009-P-0273-0002,FDA,FDA-2009-P-0273,"Acknowledgement Letter to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2009-06-18T04:00:00Z,2009,6,2009-06-18T04:00:00Z,,2013-08-11T04:33:51Z,,0,0,09000064809d0b46